Nkosi-Gondwe, Thandile
Robberstad, Bjarne
Opoka, Robert
Kalibbala, Dennis
Rujumba, Joseph
Galileya, Lufina Tsirizani
Akun, Pamela
Nambatya, Winnie
Ssenkusu, John
TerKuile, Feiko
Phiri, Kamija
Idro, Richard
Funding for this research was provided by:
This study is funded by the Research Council of Norway, Global Health and Vaccination Research (GLOBVAC) programme (285284)
Article History
Received: 9 March 2023
Accepted: 24 March 2023
First Online: 5 April 2023
Declarations
:
: This protocol, the informed consent documents and the patient information sheets have been reviewed and approved by the Makerere University School of Medicine Research and Ethics Committee (SOMREC) (protocol #2020–103), the Liverpool School of Tropical Medicine Research Ethics Committee (protocol #19.105), the Regional Committee for Medical and Health Research Ethics, western Norway (REK vest) (protocol #30992) and the National Health Sciences Research Committee (NHSRC) in Malawi (protocol #19/11/2442). The study was also approved by the following regulatory authorities: Uganda National Council for Science and Technology (HS709ES), the National Drug Authority in Uganda (CTA 0149/2020) and the Malawi Poisons and Medicines Board (05102020123).
: Not applicable.
: The authors declare that they have no competing interests.